Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pharmaceutical sales exceeded consensus and analyst estimates, while diagnostics fell short of market expectations. Roche confirmed its full-year guidance; pharma results included a one-time Japan inventory effect tied to a new ERP system.
East West Bancorp reported record Q3 2026 revenue, net interest income and diluted EPS. It raised full-year net interest income growth guidance to 9–10% and lowered its full-year net charge-off guidance.
Home BancShares reported record third-quarter earnings and said it paid a new dividend of $0.23 per share, described as a 9.5% increase. The company also repurchased 1.3 million shares for approximately $39.3 million during the quarter.
On Thursday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Lineage Ce
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv
BeiGene (NASDAQ: ONC ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary BeiGene reported strong Q2 2026 financial results with $1.7 billion in t
Recursion Pharmaceuticals (NASDAQ: RXRX ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Recursion Pharma